Experimental therapy halts treatment-resistant brain tumors in mouse model

Researchers report an experimental therapy that in laboratory tests stops aggressive, treatment-resistant and deadly brain cancers called glioblastoma and high-grade gliomas. Testing a multi-step therapeutic strategy, the scientists found a way to use a gene therapy to shut down a gene long-implicated in the formation of high-grade gliomas called Olig2.